Enova (ENVA) Form 144: David Fisher sold shares

Enova International reported reported Form 144 sales of common stock by David Fisher.

Rhea-AI Filing Summary

Enova International reported reported Form 144 sales of common stock by David Fisher. The excerpt lists sales on 11/21/2025 of 6,000 shares for $745,289.01, on 12/16/2025 of 15,000 shares for $2,403,060.39, on 01/26/2026 of 9,573 shares for $1,510,288.39, and on 01/30/2026 of 37,989 shares for $6,278,649.23.

Insights

Corporate Governance Analyst

Multiple affiliate sales by a single reporting person are disclosed across late 2025 and January 2026.

These entries list four separate common stock transactions by David Fisher with precise dates, share counts, and gross proceeds in dollars. Each row ties a sale date to a share quantity and an aggregate dollar amount.

These are transactional disclosures of past sales; their investment impact depends on other holdings and market context not provided in the excerpt.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Enova International (ENVA) disclose in this Form 144?

The filing discloses Form 144 sales of common stock by David Fisher on specific dates. The excerpt shows four sales on 11/21/2025, 12/16/2025, 01/26/2026, and 01/30/2026 with listed share counts and dollar amounts.

How many shares did David Fisher sell and what were the proceeds?

The excerpt lists four sales totaling specified per‑trade amounts, not an aggregate total. Examples: 6,000 shares for $745,289.01 and 37,989 shares for $6,278,649.23, as shown on the respective dates.

Does the Form 144 show who received the sale proceeds?

The excerpt ties each sale to an aggregate dollar amount but does not state who received proceeds. The rows show gross proceeds per sale; the recipient or use of proceeds is not specified in the provided excerpt.

Are these sales reported as completed transactions or notices of intent?

The excerpt is a Form 144 record listing securities sold during the past three months. It presents completed sale dates and amounts in the table; the filing format here documents those transactions rather than only an intent to sell.

Where can I find the dates and amounts for each sale?

Each transaction row in the excerpt includes a sale date, share count, and aggregate dollar amount. For example, 12/16/2025 shows 15,000 shares and $2,403,060.39 in proceeds directly in the table.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/18/2026 - 11:06 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001315224
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Enova International
SEC File Number	001-35503
Address of Issuer	175West Jackson Blvd Suite 600 Chicago ILLINOIS 60604
Phone	3125684200
Name of Person for Whose Account the Securities are To Be Sold	David Fisher
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 110 N Wacker Dr, Ste 1900 Chicago IL 60606	7143	1071450	24801579	02/18/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/08/2022	Stock Bonus	Enova International			7143	02/08/2022	Stock Bonus

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David Fisher 175 West Jackson Blvd, Ste 600 Chicago IL 60604	Common	11/21/2025	6000	745289.01
David Fisher 175 West Jackson Blvd, Ste 600 Chicago IL 60604	Common	12/16/2025	15000	2403060.39
David Fisher 175 West Jackson Blvd, Ste 600 Chicago IL 60604	Common	01/26/2026	9573	1510288.39
David Fisher 175 West Jackson Blvd, Ste 600 Chicago IL 60604	Common	01/30/2026	37989	6278649.23

144: Remarks and Signature

Remarks
Date of Notice	02/18/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/20/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	David Fisher
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)